Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
DexCom (DXCM) PT Lowered to $553 at Cowen
February 11, 2022 7:26 AM ESTCowen analyst Joshua Jennings lowered the price target on DexCom (NASDAQ: DXCM) to $553.00 (from $655.00) while maintaining an Outperform rating.
The analyst commented, "After releasing its 4Q21 sales results and 2022 revenue guidance last month, DXCM today reported its full 4Q21 results and provided its 2022... More
DexCom (DXCM) Misses Q4 EPS by 17c
February 10, 2022 4:05 PM ESTDexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96... More



